Acknowledgement
Does ‘NICE blight’ exist, and if so, why?
Modelling Downstream Effects in the Presence of Technological Change
Measuring US Pharmaceutical Industry R&D Spending
Management and Prevention of Diabetic Foot Ulcers and Infections : A Health Economic Review
Single Technology Appraisals by NICE : Are They Delivering Faster Guidance to the NHS?
A Cost-Utility Comparison of Four First-Line Medications in Painful Diabetic Neuropathy
Essentials of Pharmacoeconomics